CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021)
CollPlant Biotechnologies (CLGN) posted Interest & Investment Income of -$188.8 million for Q4 2021, down 381.76% on a QoQ basis from $67.0 million in Q3 2021, and down 1013.1% year-over-year from $20.7 million in Q4 2020.
CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021) Analysis & Trends
CollPlant Biotechnologies' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$188.8 million for Q4 2021.
- Quarterly Interest & Investment Income fell 1013.1% year-over-year to -$188.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$121.7 million (down 304247.5% YoY) and the FY2025 annual result came in at $380000.0, down 48.51% from the prior year.
- Interest & Investment Income was -$188.8 million for Q4 2021 at CollPlant Biotechnologies, down from $67.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $67.0 million in Q3 2021 and bottomed at -$188.8 million in Q4 2021.
- A 5-year average of -$8.1 million and a median of $9000.0 in 2020 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2019 — Interest & Investment Income jumped 1440.43% — and 2021, when it slumped 1013.1%.
- CollPlant Biotechnologies' Interest & Investment Income stood at -$81000.0 in 2017, then jumped by 666.67% to $459000.0 in 2018, then soared by 37.25% to $630000.0 in 2019, then plunged by 2792.06% to -$17.0 million in 2020, then slumped by 1013.1% to -$188.8 million in 2021.
- Business Quant data shows CLGN's Interest & Investment Income at -$188.8 million in Q4 2021, $67.0 million in Q3 2021, and $72000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -188.78 Mn |
| Sep 30, 2021 | 67.00 Mn |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Dec 31, 2020 | -16.96 Mn |
| Sep 30, 2020 | 16.97 Mn |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Jun 30, 2019 | 630,000.00 |
| Mar 31, 2019 | -16,000.00 |
| Dec 31, 2018 | 459,000.00 |
| Sep 30, 2018 | -106,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Mar 31, 2018 | -112,000.00 |
| Dec 31, 2017 | -81,000.00 |